These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 12219111)
21. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum. Martinucci M; Roscetto E; Iula VD; Votsi A; Catania MR; De Gregorio E Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758 [TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. Cunha MV; Leitão JH; Mahenthiralingam E; Vandamme P; Lito L; Barreto C; Salgado MJ; Sá-Correia I J Clin Microbiol; 2003 Sep; 41(9):4113-20. PubMed ID: 12958234 [TBL] [Abstract][Full Text] [Related]
23. Pseudomonas cepacia in the sputum of cystic fibrosis patients. Taylor PC; Kalamatianos CC Pathology; 1994 Jul; 26(3):315-7. PubMed ID: 7527513 [TBL] [Abstract][Full Text] [Related]
24. Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. Biddick R; Spilker T; Martin A; LiPuma JJ FEMS Microbiol Lett; 2003 Nov; 228(1):57-62. PubMed ID: 14612237 [TBL] [Abstract][Full Text] [Related]
25. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Coenye T; LiPuma JJ; Henry D; Hoste B; Vandemeulebroecke K; Gillis M; Speert DP; Vandamme P Int J Syst Evol Microbiol; 2001 Mar; 51(Pt 2):271-9. PubMed ID: 11321071 [TBL] [Abstract][Full Text] [Related]
26. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. Henry D; Campbell M; McGimpsey C; Clarke A; Louden L; Burns JL; Roe MH; Vandamme P; Speert D J Clin Microbiol; 1999 Apr; 37(4):1004-7. PubMed ID: 10074517 [TBL] [Abstract][Full Text] [Related]
27. PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection. Shreve MR; Johnson SJ; Milla CE; Wielinski CL; Regelmann WE Am J Respir Crit Care Med; 1997 Mar; 155(3):984-9. PubMed ID: 9117036 [TBL] [Abstract][Full Text] [Related]
29. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis. Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis. Preece CL; Wichelhaus TA; Perry A; Jones AL; Cummings SP; Perry JD; Hogardt M J Clin Microbiol; 2016 Jul; 54(7):1797-1803. PubMed ID: 27098962 [TBL] [Abstract][Full Text] [Related]
31. Occurrence of Burkholderia cepacia in the hospital environment. Moore JE; McIlhatton B; Buchanan J; Gilpin D; Shaw A; Hall V; Murphy PG; Elborn JS Ir J Med Sci; 2002; 171(3):131-3. PubMed ID: 15736349 [TBL] [Abstract][Full Text] [Related]
32. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Ledson MJ; Gallagher MJ; Jackson M; Hart CA; Walshaw MJ Thorax; 2002 Feb; 57(2):142-5. PubMed ID: 11828044 [TBL] [Abstract][Full Text] [Related]
33. Molecular typing of, and distribution of genetic markers among, Burkholderia cepacia complex isolates from Brazil. Detsika MG; Corkill JE; Magalhães M; Glendinning KJ; Hart CA; Winstanley C J Clin Microbiol; 2003 Sep; 41(9):4148-53. PubMed ID: 12958239 [TBL] [Abstract][Full Text] [Related]
34. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. Shelly DB; Spilker T; Gracely EJ; Coenye T; Vandamme P; LiPuma JJ J Clin Microbiol; 2000 Aug; 38(8):3112-5. PubMed ID: 10921992 [TBL] [Abstract][Full Text] [Related]
35. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital. Siddiqui AH; Mulligan ME; Mahenthiralingam E; Hebden J; Brewrink J; Qaiyumi S; Johnson JA; LiPuma JJ Infect Control Hosp Epidemiol; 2001 Jul; 22(7):419-22. PubMed ID: 11583209 [TBL] [Abstract][Full Text] [Related]
36. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex. Herasimenka Y; Cescutti P; Impallomeni G; Campana S; Taccetti G; Ravenni N; Zanetti F; Rizzo R J Cyst Fibros; 2007 Apr; 6(2):145-52. PubMed ID: 16860003 [TBL] [Abstract][Full Text] [Related]
37. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. Agodi A; Mahenthiralingam E; Barchitta M; Gianninò V; Sciacca A; Stefani S J Clin Microbiol; 2001 Aug; 39(8):2891-6. PubMed ID: 11474009 [TBL] [Abstract][Full Text] [Related]
38. Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. Bevivino A; Dalmastri C; Tabacchioni S; Chiarini L; Belli ML; Piana S; Materazzo A; Vandamme P; Manno G J Clin Microbiol; 2002 Mar; 40(3):846-51. PubMed ID: 11880403 [TBL] [Abstract][Full Text] [Related]
39. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. Chen JS; Witzmann KA; Spilker T; Fink RJ; LiPuma JJ J Pediatr; 2001 Nov; 139(5):643-9. PubMed ID: 11713440 [TBL] [Abstract][Full Text] [Related]